Motor neuron disease/amyotrophic lateral sclerosis
Frontostriatal deficit in Motor Neuron Disease/Amyotrophic Lateral Sclerosis (MND/ALS)
6
Frequency and risk factor analysis of cognitive and anxiety-depressive disorders in patients with amyotrophic lateral sclerosis/motor neuron disease
8
The use of full setting non invasive ventilation in the home care of people with amyotrophic lateral sclerosis motor neuron disease with end stage respiratory muscle failure: a case series
6
Sharing and empathy in digital spaces: qualitative study of online health forums for breast cancer and motor neuron disease. (Amyotrophic Lateral Sclerosis)
22
Amyotrophic lateral sclerosis motor neuron disease, monoclonal gammopathy, hyperparathyroidism, and B12 deficiency: case report and review of the literature
7
Evaluating a novel cervical orthosis, the Sheffield Support Snood, in patients with amyotrophic lateral sclerosis/motor neuron disease with neck weakness
19
Identification and outcomes of clinical phenotypes in amyotrophic lateral sclerosis/motor neuron disease: Australian National Motor Neuron Disease observational cohort
7
Evaluating a novel cervical orthosis, the Sheffield Support Snood, in patients with amyotrophic lateral sclerosis/motor neuron disease with neck weakness
21
Focus on the Role of D-serine and D-amino Acid Oxidase in Amyotrophic Lateral Sclerosis/Motor Neuron Disease (ALS)
7
Dominantly Inherited Amyotrophic Lateral Sclerosis (Motor Neuron Disease)
5
Establishing the UK DNA Bank for motor neuron disease (MND)
9
A blended psychosocial support program for partners of patients with amyotrophic lateral sclerosis and progressive muscular atrophy: protocol of a randomized controlled trial
11
Original Article Anesthetic strategy for percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis patients
6
Widespread aggregation of mutant VAPB associated with ALS does not cause motor neuron degeneration or modulate mutant SOD1 aggregation and toxicity in mice
16
Advanced magnetic resonance neuroimaging in bulbar and limb onset early amyotrophic lateral sclerosis.
7
Caregiving in ALS A mixed methods approach to the study of Burden
12
Stigma, perceived control and health related quality of life for individuals experiencing Parkinson’s disease
343
Clinical Reasoning: A 42-year-old man with unilateral leg weakness
7
Riluzole: real-world evidence supports significant extension of median survival times in patients with amyotrophic lateral sclerosis
10
Astrocyte adenosine deaminase loss increases motor neuron toxicity in amyotrophic lateral sclerosis
21